Clinical trial
Long Term observAtional, Prospective, Multicenter Study to Collect iN a Real-world populatIon Data on the treatMent Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (ANIMA)
NCT05921994 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term observAtional, Prospective, Multicenter Study to Collect iN a Real-world populatIon Data on the treatMent Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (ANIMA)
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 10, 2023
- Completion date
- March 31, 2027
- Enrollment
- 436 (actual)
- Sites
- 80
Conditions
As the registry lists them; a condition with its own page is linked.